Welcome to the ISPPD 2022 Meeting Calendar

To check the meeting times in your local time zone Click Here

             

4 Sessions
Session Type
  • Industry-Sponsored Symposium
 Filtered By

Sort By Session date and time

Industry Sponsored Symposium 01 (a non-accredited Industry Sponsored Symposium and is NOT part of the accredited main event)

Session Type
Industry-Sponsored Symposium
Date
Mon, 20.06.2022
Session Time
07:15 - 08:45
Room
Grand Ballroom Centre
Chair(s)
Session Description
Improving on Two Decades of Protection: The Legacy and Future Potential of PCVs - Supported by Pfizer

Industry Sponsored Symposium 02 (a non-accredited Industry Sponsored Symposium and is NOT part of the accredited main event)

Session Type
Industry-Sponsored Symposium
Date
Mon, 20.06.2022
Session Time
12:45 - 13:45
Room
Grand Ballroom Centre
Chair(s)
Session Description
Advanced Understanding of Pneumonia: from Pathogenesis to Prevention - Industry Symposium Supported by GlaxoSmithKline Biologicals SA

Session Description:

Based on the lessons we learnt from the pandemic, the GSK symposium will look at our understanding of pneumonia, its pathogenesis, and prevention. Prof. Shabir Madhi will discuss pneumonia pathogenesis with a focus on bacterial and viral interplay. Prof. Peter Richmond will cover different aspects of pneumonia prevention. Lastly Prof. Susanna Esposito will discuss challenges of the implementation of preventive vaccine programs.

Industry Sponsored Symposium 03 (a non-accredited Industry Sponsored Symposium and is NOT part of the accredited main event)

Session Type
Industry-Sponsored Symposium
Date
Tue, 21.06.2022
Session Time
07:15 - 08:45
Room
Grand Ballroom Centre
Chair(s)
Session Description
A New Paradigm for Adult Pneumococcal Disease Prevention- Supported by Merck

Industry Sponsored Symposium 04 (a non-accredited Industry Sponsored Symposium and is NOT part of the accredited main event)

Session Type
Industry-Sponsored Symposium
Date
Wed, 22.06.2022
Session Time
07:30 - 08:30
Room
Grand Ballroom Centre
Chair(s)
Session Description
Product and Clinical development of a 10-valent Pneumococcal Conjugate Vaccine (PNEUMOSIL®) - Supported by Serum Institute of India
A new Polysaccharide Conjugate Vaccine, PNEUMOSIL® has been licensed by Government of India and prequalified by WHO. This session covers the CMC and Clinical development of this vaccine which is likely to make a very positive public health impact in MICs and LMICs.